Anna Z. Amar
About Anna Z. Amar
Anna Z. Amar serves as the Director of the Division of Compliance Management at the National Institutes of Health, where she has contributed significantly to technology transfer initiatives and compliance processes. With extensive experience in various roles within the NIH and a strong academic background in immunology, she has played a key role in shaping training programs and agreements related to clinical trials.
Current Role at National Institutes of Health
Anna Z. Amar serves as the Director of the Division of Compliance Management within the Office of Management Assessment at the National Institutes of Health (NIH). She has held this position since 2019, overseeing compliance management initiatives and ensuring adherence to regulatory standards within the organization. Her role involves strategic leadership and the implementation of policies that support the NIH's mission in health research and technology transfer.
Previous Positions at National Institutes of Health
Anna Z. Amar has held several significant roles at the National Institutes of Health prior to her current position. She worked as the Acting Deputy Director of the Technology Advancement Office at the National Institute of Diabetes & Digestive & Kidney Diseases from 2010 to 2016. Additionally, she served as the Acting Branch Chief in the Extramural Branch of the Office of Technology Development at the National Institute of Allergy and Infectious Diseases from 2009 to 2010. Her experience also includes roles as a Technology Transfer Specialist and Lead Technology Development Associate.
Education and Expertise
Anna Z. Amar studied at Murdoch University, where she earned a Bachelor of Science with Honors in Biology/Immunology and pursued a PhD in Immunology, achieving ABD status. Her educational background provides a strong foundation for her expertise in technology transfer and compliance management within the biomedical field. She also attended Wellington Girls College, which contributed to her early academic development.
Contributions to Technology Transfer Initiatives
Anna Z. Amar has made significant contributions to technology transfer initiatives through her participation in various committees and working groups. She chaired the Public Health Service Technology Transfer Working Group, focusing on enhancing technology transfer processes. Additionally, she led the NIAID Agreements for Clinical Trials Working Group, which developed and managed agreements related to clinical trials. Her involvement in the Training and Education Subcommittee of the Public Health Service Technology Transfer Policy Board further underscores her commitment to advancing the field.
Speaking Engagements and Professional Involvement
Anna Z. Amar has been an invited speaker at prominent industry conferences, including the Biotechnology Industry Organization (BIO) Convention and the American Conference Institute (ACI). Through these engagements, she shares her expertise in technology transfer and compliance management, contributing to the broader dialogue in the field. Her role as the NIH Representative for the Federal Laboratory Consortium highlights her commitment to fostering collaboration and technology transfer between federal laboratories and external partners.